Diversified Healthcare Trust [DHC] stock prices are up 1.35% to $2.26 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DHC shares have gain 9.18% over the last week, with a monthly amount drifted -7.76%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wells Fargo downgraded its rating to Underweight on December 10, 2020, and kept the price target unchanged to $4. Wells Fargo downgraded its rating to a Equal Weight but stick to its price target of $9 on January 17, 2020.
The stock price of Diversified Healthcare Trust [DHC] has been fluctuating between $2.00 and $4.24 over the past year. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Diversified Healthcare Trust [NASDAQ: DHC] shares were valued at $2.26 at the most recent close of the market. An investor can expect a potential return of 121.24% based on the average DHC price forecast.
Analyzing the DHC fundamentals
The Diversified Healthcare Trust [NASDAQ:DHC] reported sales of 1.50B for trailing twelve months, representing a surge of 5.00%. Gross Profit Margin for this corporation currently stands at 0.08% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.25%, and Net Profit Margin reading is -0.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.18 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.18 points at the first support level, and at 2.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.31, and for the 2nd resistance point, it is at 2.36.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 0.36, the price to book ratio is 0.28.
Transactions by insiders
Recent insider trading involved Brown Matthew C., CFO and Treasurer, that happened on Nov 13 ’24 when 2000.0 shares were purchased.
